Skip to content
info@acplgroupindia.co.in +91-9266665201 Mon – Sat: 10:00 AM – 6:00 PM
Accredited Consultant
  • Home
  • About
  • Services

    • Regulatory Services

      • CDSCO Registration
      • FSSAI Licensing
      • BIS Certification
      • DGFT Approvals
      • WPC Approval
      • EPR Registration
      • Legal Metrology

    • Specialized Services

      • Pharmacovigilance
      • Cosmetovigilance
      • Materiovigilance
      • Food Safety Vigilance
      • Clinical Trials
      • Field Safety Trials

    • More Services

      • DSIR Recognition
      • ICMR Approvals
      • NPPA Compliance
      • Narcotics (CBN)
      • PCPNDT Compliance
      • India Entry Strategy
  • India Entry
  • New Letter
    • Volume 22
    • Volume 23
    • Volume 24
    • Volume 25
    • Volume 26
    • Volume 27
    • Volume 28
    • Volume 29
  • Blog
  • Contact
Get Started
Accredited Consultant
  • Home
  • About
  • Services
    • Regulatory Services
      • CDSCO Registration
      • FSSAI Licensing
      • BIS Certification
      • DGFT Approvals
      • WPC Approval
      • EPR Registration
      • Legal Metrology
    • Specialized Services
      • Pharmacovigilance
      • Cosmetovigilance
      • Materiovigilance
      • Food Safety Vigilance
      • Clinical Trials
      • Field Safety Trials
    • More Services
      • DSIR Recognition
      • ICMR Approvals
      • NPPA Compliance
      • Narcotics (CBN)
      • PCPNDT Compliance
      • India Entry Strategy
  • India Entry
  • New Letter
    • Volume 22
    • Volume 23
    • Volume 24
    • Volume 25
    • Volume 26
    • Volume 27
    • Volume 28
    • Volume 29
  • Blog
  • Contact
Call Us: +91-9266665201 info@acplgroupindia.co.in
  1. Home
  2. Central drugs registration in india

Central drugs registration in india

December 4, 2025 drug & medical registration
← Previous drug & medical registration in India Next → New drug & medical registration in India

Recent Posts

  • CPCB’s New “Lost Credentials” Facility: A Simple Guide for EPR Portal Users Aug 14, 2026
  • CDSCO Clarifies Regulatory Pathway for Globally Unapproved New Drugs After Phase III Global Clinical Trials Aug 12, 2026
  • BIS Certification: Important Reasons Why Your BIS Application Gets Rejected Aug 10, 2026
  • CDSCO’s Digital Overhaul 2026: DDRS Tender, SUGAM & eCTD Status Aug 10, 2026
  • CDSCO Guidance on Common Submission Format for Drug Imports in India: What Pharma Companies Really Need to Know Aug 6, 2026

Need Regulatory Guidance?

Our team of 18+ experts is ready to help with your regulatory challenges.

Contact Us
Accredited Consultant

India's trusted pharma regulatory affairs consultancy. Over 25 years helping businesses navigate CDSCO, FSSAI, BIS, and all major Indian regulatory frameworks.

Quick Links

  • About ACPL
  • Our Services
  • India Entry Strategy
  • Insights & Blog
  • Contact Us
  • Careers

Key Services

  • CDSCO Registration
  • FSSAI Licensing
  • BIS Certification
  • Pharmacovigilance
  • Clinical Trials
  • EPR Registration

Contact Us

  • B-3, Sector-6, Noida – 201301, Uttar Pradesh, India
  • +91-9266665201
    +91-9310040434
  • info@acplgroupindia.co.in
  • Mon – Sat: 10:00 AM – 6:00 PM

© 2026 Accredited Consultants Private Limited. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
Scroll to Top